RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Clinical trial NCT05869669 · COMPLETED
Trial details
- NCT number
- NCT05869669
- Sponsor
- EIP Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2025-05-29
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.